Skip to content

Clinical trials

Completed Bipolar Disorder trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bipolar Disorder Status: Completed Country / region: South Korea Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20061
20074
20081
20101
20131
20141
20221
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Korea Otsuka Pharmaceutical Co., Ltd.3
AstraZeneca2
Sumitomo Pharma America, Inc.2
Asan Medical Center1
Dong-Wook Kim1
Eli Lilly and Company1
Hucircadian1
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.1
Seoul National University Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bipolar Disorder13
Schizophrenia2
Affective Disorders, Psychotic1
Autistic Disorder1
Major Depressive Disorder1
Mania1
Metabolic Syndrome1
Mood Disorders1
Overweight1
Weight Gain1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.